# Bell Biosystems, Berkeley, United States

> Bell Biosystems: Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.

Source: https://millionrounds.com/startup/bell-biosystems (Millionrounds; every figure on the page links to its filing or article)

United States · [Startup](https://millionrounds.com/companies)

# Bell Biosystems

Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.

Email

Funding reported Last round: Series A

Berkeley, United States

Follow Bell Biosystems and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fbell-biosystems)

Company summary

- **Founded:** 2009 17 years old
- **Team:** 1 1 to 10 people
- **Funding reported:** $9.1M in dollars
- **Last round:** Series A Apr 2015

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Bell Biosystems has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Bell Biosystems raised

Funding, as reported

Reported in all **$9.1M** in dollars

Rounds **3**

Last round **Series A**

Last round size **$3.8M**

Last round date **Apr 2015**

Investors listed **3**

SEC Form D **$6.2M sold, 4 filings, last Apr 2015**

## Funding filed with regulators

Bell Biosystems filed 3 raises, $4.2M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Dec 2013 **$3.8M** 25 investors equity SEC Form D
- May 2012 **$250K** 3 investors equity, debt, options, securities on exercise of $2.0M offered SEC Form D
- Jun 2011 **$120K** 9 investors equity, debt, options, securities on exercise SEC Form D

## Founders and team

From the SEC filings it signed: 1 on the team.

- **Daniel B. Bell** Executive Officer i

On the board, as filed i *Christian B. Olgaard* *Gil B. Van Bokkelen* *Stuart B. Berman* *Una B. Ryan*

## On a portfolio page

Investors who name them

- [The Angels' Forum](https://millionrounds.com/fund/the-angels-forum)

Each firm lists Bell Biosystems on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Built with from their website

Amazon AWS

- **Region:** California
- **Revenue:** $674K a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/bell-biosystems)

## Is this your company?

Add your raise, your deck and your story, and put Bell Biosystems in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)